VanEck Associates’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4M Sell
51,888
-4,959
-9% -$1.28M 0.02% 409
2025
Q1
$12.7M Buy
56,847
+15,568
+38% +$3.48M 0.02% 411
2024
Q4
$9.44M Buy
41,279
+1,945
+5% +$445K 0.01% 483
2024
Q3
$9.34M Buy
39,334
+1,121
+3% +$266K 0.01% 464
2024
Q2
$7.31M Buy
38,213
+11,629
+44% +$2.23M 0.01% 491
2024
Q1
$5.26M Buy
26,584
+735
+3% +$146K 0.01% 562
2023
Q4
$4.45M Sell
25,849
-5,713
-18% -$983K 0.01% 575
2023
Q3
$4.67M Buy
31,562
+693
+2% +$102K 0.01% 521
2023
Q2
$6.75M Buy
30,869
+3,771
+14% +$824K 0.01% 434
2023
Q1
$5.93M Buy
27,098
+6,845
+34% +$1.5M 0.01% 450
2022
Q4
$4.22M Buy
20,253
+3,019
+18% +$628K 0.01% 512
2022
Q3
$3.76M Buy
17,234
+2,114
+14% +$461K 0.01% 496
2022
Q2
$3.17M Sell
15,120
-209
-1% -$43.8K 0.01% 563
2022
Q1
$3.72M Buy
15,329
+1,502
+11% +$364K 0.01% 571
2021
Q4
$3.6M Sell
13,827
-481
-3% -$125K 0.01% 581
2021
Q3
$3.77M Sell
14,308
-2,374
-14% -$626K 0.01% 521
2021
Q2
$4.11M Buy
16,682
+11
+0.1% +$2.71K 0.01% 493
2021
Q1
$3.24M Buy
16,671
+1,919
+13% +$372K 0.01% 511
2020
Q4
$3.14M Buy
14,752
+4,214
+40% +$896K 0.01% 463
2020
Q3
$1.81M Buy
10,538
+2,162
+26% +$371K 0.01% 514
2020
Q2
$1.61M Buy
8,376
+1,671
+25% +$321K 0.01% 526
2020
Q1
$988K Buy
6,705
+670
+11% +$98.7K 0.01% 574
2019
Q4
$935K Buy
6,035
+5,330
+756% +$826K ﹤0.01% 656
2019
Q3
$95K Buy
705
+110
+18% +$14.8K ﹤0.01% 755
2019
Q2
$73K Buy
+595
New +$73K ﹤0.01% 762
2018
Q2
Sell
-98
Closed -$10K 861
2018
Q1
$10K Buy
+98
New +$10K ﹤0.01% 732
2017
Q2
Sell
-1,945
Closed -$140K 853
2017
Q1
$140K Buy
1,945
+136
+8% +$9.79K ﹤0.01% 720
2016
Q4
$112K Sell
1,809
-94
-5% -$5.82K ﹤0.01% 720
2016
Q3
$123K Buy
1,903
+516
+37% +$33.4K ﹤0.01% 700
2016
Q2
$88K Buy
1,387
+330
+31% +$20.9K ﹤0.01% 698
2016
Q1
$61K Buy
1,057
+165
+18% +$9.52K ﹤0.01% 715
2015
Q4
$48K Buy
892
+243
+37% +$13.1K ﹤0.01% 680
2015
Q3
$33K Buy
649
+99
+18% +$5.03K ﹤0.01% 730
2015
Q2
$31K Buy
550
+109
+25% +$6.14K ﹤0.01% 738
2015
Q1
$32K Buy
441
+209
+90% +$15.2K ﹤0.01% 723
2014
Q4
$13K Buy
+232
New +$13K ﹤0.01% 756